Xenon Pharmaceuticals XENE
NASDAQ XENE
$36.27 +1.19 (+3.39%)
At close: Oct 20, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Share-based Compensation (IS) (2014 - 2015)

Updated

Xenon Pharmaceuticals (XENE) posted Share-based Compensation (IS) of -$1.88 million for Q2 2015, compared with $141,000 a year earlier.

Analysis

Xenon Pharmaceuticals (XENE) Share-based Compensation (IS) (2014 - 2015) Analysis & Trends

For the trailing twelve months through Jun 30, 2015, Share-based Compensation (IS) at Xenon Pharmaceuticals was $3.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Xenon Pharmaceuticals 3.62 Bn 581.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -1.88 Mn
Mar 31, 2015 5.15 Mn
Jun 30, 2014 141,000.00
Mar 31, 2014 136,000.00
API Access

Xenon Pharmaceuticals Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=XENE&period=max&api_key=YOUR_API_KEY